Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000223270 | SCV000270022 | benign | not specified | 2017-03-31 | criteria provided, single submitter | clinical testing | p.Lys426Glu in Exon 10 of CCDC50: This variant is not expected to have clinical significance because it has been identified in 0.5% (131/24026) of African chrom osomes including 1 homozygote by the Genome Aggregation Database (http://gnomad. broadinstitute.org/; dbSNP rs114146378). |
Invitae | RCV000896233 | SCV001040315 | likely benign | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000896233 | SCV001813329 | likely benign | not provided | 2020-11-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917891 | SCV004730992 | benign | CCDC50-related condition | 2019-05-23 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV000223270 | SCV001550415 | benign | not specified | no assertion criteria provided | clinical testing | The CCDC50 p.K426E variant was not identified in the literature but was identified in dbSNP (ID: rs114146378) and ClinVar (classified as likely benign by Invitae and as benign by Laboratory for Molecular Medicine). The variant was identified in control databases in 143 of 282448 chromosomes (1 homozygous) at a frequency of 0.0005063, and was observed at the highest frequency in the African population in 135 of 24962 chromosomes (1 homozygous) (freq: 0.005408) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.K426 residue is not conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) do not suggest a high likelihood of impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. |